Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.

Wang BZ, Liu W, Kang SM, Alam M, Huang C, Ye L, Sun Y, Li Y, Kothe DL, Pushko P, Dokland T, Haynes BF, Smith G, Hahn BH, Compans RW.

J Virol. 2007 Oct;81(20):10869-78. Epub 2007 Aug 1.

2.

Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins.

Kothe DL, Decker JM, Li Y, Weng Z, Bibollet-Ruche F, Zammit KP, Salazar MG, Chen Y, Salazar-Gonzalez JF, Moldoveanu Z, Mestecky J, Gao F, Haynes BF, Shaw GM, Muldoon M, Korber BT, Hahn BH.

Virology. 2007 Mar 30;360(1):218-34. Epub 2006 Nov 13.

3.

Ancestral and consensus envelope immunogens for HIV-1 subtype C.

Kothe DL, Li Y, Decker JM, Bibollet-Ruche F, Zammit KP, Salazar MG, Chen Y, Weng Z, Weaver EA, Gao F, Haynes BF, Shaw GM, Korber BT, Hahn BH.

Virology. 2006 Sep 1;352(2):438-49. Epub 2006 Jun 14.

4.

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.

Li M, Gao F, Mascola JR, Stamatatos L, Polonis VR, Koutsoukos M, Voss G, Goepfert P, Gilbert P, Greene KM, Bilska M, Kothe DL, Salazar-Gonzalez JF, Wei X, Decker JM, Hahn BH, Montefiori DC.

J Virol. 2005 Aug;79(16):10108-25.

Supplemental Content

Loading ...
Support Center